The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
A bit more
https://probiotixhealth.com/free-product-trial-vitafoods/
mol
In fact all product info flyers updated May 2024 - see product info
https://probiotixhealth.com/products/
mol
mol
Flyer uploaded May 2024
https://probiotixhealth.com/wp-content/uploads/2024/05/YourBiotix-InstaMelt-For-Cholesterol-Health-1.pdf
mol
Catherine O'Neill
Applied Feb 22
Published Apr 24
https://patents.justia.com/patent/20240131089#history
not assigned as yet to skin apparently
others
https://patents.justia.com/inventor/catherine-o-neill
mol
C6 hrs ago
We are delighted to have recently signed a new partnership agreement with Morepen for SlimBiome®!
‘We are pleased to announce this agreement with Morepen, a well-known and trusted supplier to pharmacies, physicians, and retail customers across India.
Morepen brings an extensive sales team with experience of highly differentiated scientific products and countrywide access to a network of around 500,000 pharmacies across India.
Based on current forecasts, the Directors anticipate this agreement could contribute in the region of £6-7 million revenue per annum in the next four to five years.’ – Stephen O’Hara, CEO of OptiBiotix
Let's wait and see what it actually generates in 2nd half 2024 and 1st half 2025 - mind we won't know former until probably this time next year (no rodders pun intended) and the latter probably not until full year 2025 disclosed ie circa may 2026
unless of course an indication given prior
i'm sure the forecasts didn't start from 4-5 years time
mol
If so aquae considering
Strong first half of trading with sales of £351k (2022: £119k), a 195% increase over H1 2022. Given H1 2022 included £19.5k from Probiotic sales up to March 30 2022, the 'like for like' increase is 251%. 85% of this sales income was received in Q2 2023
and
“The aim for the second half of the year is to maintain our focus on managing costs, growing sales and closing out ongoing discussions with a number of larger partners across first and second-generation products to ensure a return on investment from the expansion of our commercial and business development teams. We are particularly excited about our second-generation products approaching commercialisation given their uniqueness in the marketplace. Our sweet prebiotic fibres, called SweetBiotix® create the opportunity to replace unhealthy calorific and cariogenic sugars with healthy fibres in a wide range of food and beverage products. With growing health concerns over traditional sugars and sweeteners, the commercialisation of SweetBiotix® meets a large global market need. After many years of hard work we are equally pleased at the significant progress we have made in 2023 in the manufacturing scale up our microbiome modulators which selectively enhance the growth rate of specific types of bacteria and create the potential for targeted treatment of a range of human diseases. We believe these unique products, individually and collectively, offer shareholders the potential for a significant enhancement in the value of the Company.
very disappointing outturn for 2023
albeit unfortunately i don't think your forecast figure is too far out
i really hope we are both wrong - not long to wait
mol
After opti being one of the most best performing shares on aim in 2023 - a fact Stephen but basically a calculating and selective statement disregarding the past
we had
PBX - must be one of the most undervalued shares on any market
jees really Stephen - twas yourself who listed same on probably the most illiquid market to save money apparently
and then at end of presentation you pushed any questions on PBX to either the company CEO or Walbrook which neatly
sidestepped any conversation regarding your previous comments re relisting on PBX on AIM albeit our
44% subsidiary with you on the Board of same - i take that as meaning any relisting not coming anytime soon
mind i also look forward with interest regarding the 100% owned subsidiary of pbx as undernoted
Probiotix Health Denmark ApS
As formed after year end no mention as a 100% subsidiary within our 31 dec 2022 financial statements
https://ownr-dk.translate.goog/companies/public-profile/43827774?_x_tr_sl=da&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc
but presumably will be noted in our 2023 financial statements as a 100% subsidiary of our 44% interest
as to what the relevance its purpose has to probiotics or anything else to do with our 44% interest i'm at a loss
The purpose of the company
The company's purpose is to offer consultancy services linked to digital learning solutions and to sell digital learning platforms.
Number of employees
4 Employees (4 full-time, February 2024)
Steen the only Director
just a few observations on presentation
mol
Such a simple thing to do and file before overdue
https://find-and-update.company-information.service.gov.uk/company/11330264
anybody at home?
mol
mol
Thx lord and aquae for the updates
Extremely disappointing but unfortunately not unexpected
Also a mention in sweetbiotix update from last year
https://www.optibiotix-ir.com/content/news/archive/2023/190723
Hopefully slides available soon
Many thanks again
mol
Opti yesterday
1,979 followers
1d
People are making a life-long commitment to a drug with daily side effects.
GLP1 agonists, originally FDA approved for diabetes, have become a popular choice for weight management. These injectables mimic a hormone that convinces the brain that you feel full, reducing your hunger cravings throughout the day. The weight loss results are fast, but the cost is huge – in more ways than one.
Aside from being a generally expensive product ($900 - $1300 average), GLP1 agonists have a multitude of reported side effects, from irritable bowels to dulling the brain’s pleasure centre. According to research found in animal testing trials, some brands of GLP1 agonists are legally obliged to disclose on their packaging that consumption can cause the development of pancreatitis and thyroid cancer, with some customers already experiencing these side effects https://lnkd.in/en7d5HVd
SlimBiome is our patented weight management ingredient that has been proven to reduce hunger cravings without the need to inject anything in the body, and with no reported side effects.
mol
A plc must hold a general meeting (which can be deemed an agm) within 6 months of its year end
albeit opti have only managed this once in the last 5 years
26/07/23
26/07/22
09/07/21
09/07/20
11/06/19
mol
I would think it is for a box of 10 or 12 but being Opti not clear from upload and not from any further doodling i have been doing in the last 5 mins or so
wish they would get it right from the offset - not that difficult Shiraz
mol
Chocolate peanut bar
https://optibiotix.online/collections/snack-healthy/products/snacksmart-indulgence-bar
Uploaded c15 hours ago I think though slimbiome medical still prominent throughout on this one
mol
Heard about this on bbc world service this am
https://www.bbc.co.uk/news/articles/cd188m73vn1o
mol
Never bothered him in the past and don't see it bothering him now
he's had 10 years experience of obfuscation and missed targets, especially revenue, together with missed deadlines and other announcements which painted a more rosy expectation than that which actually transpired and so far this year and late last year nowt seems to have changed imo
keep the family salaries rolling boys
mol
C 5hours ago from the under noted
ProBiotix Health
407 followers
5h
Did you spot us in the latest edition of Nutramedic & Cosmetics in its Vitafoods Europe 2024 preview? Our innovative InstaMelt formulation is launching at the exhibition.
Visit us at stand P56 to learn more, or discover why it's great for cardiometabolic health
yes i did - lol
it's where i got the blurb as posted
https://nmc-magazine.com/vitafoods-europe-2024-preview/
mol
C 3 weeks ago
Steen Dannemann Andersen
Chief Executive Officer & Board member
3w
Dear network
Is there ANY chance that you might know someone, dynamic, driven by “hunting” and all aspects of hands-on sales and customer interaction? Someone who has 3-5 years under the belt and is ready for his or her next professional sales challenge. If you do, please, please put me in contact with that person.
I have a sales job proposal which is hard to resist, in an exceptional organization full of ambitions, entrepreneurship, team spirit and room for shaping own workday to create a healthy work/life balance.
We are committed to support healthy living under the motto “it is not about adding years to life but adding life to years”. Our dedication has led to exceptionally fast growth of the company. Our value proposition is to offer consumers clinically documented natural probiotic supplements supporting maintenance of healthy cholesterol and blood pressure levels throughout life. Our dietary supplement products are brought to market by leading regional and global companies under their own brand.
Our mission is real as almost 20 million people die from cardiovascular diseases every year of which 4 million are directly linked to elevated cholesterol levels. If our products by any means could just fractionally support lowering that numbers our mission is accomplished.
We are expanding rapidly out of our headquarters in Denmark, and the ideal profile would be someone willing to work from HQ as basis, but as the role covers sales in all of Europe, he or she also could be based in another Scandinavian or European country.
hmm...
obviously otherwise engaged martinu to provide the update noted in your approach to Walbrook
anyway 30 June 2024 rapidly approaching re 31 Dec 2023 audited financial statements due
mol